Our success in the NICU is ultimately measured by the long-term health of the children who receive intensive care as newborns. In that light, MANA physicians are committed to the success of the NICU Follow-up Program based in the Child Development Center at Goryeb Children’s Hospital.
In an effort to ensure that the parents of our patients understand the importance of comprehensive, mutlidisciplinary follow-up, professional staff from the NICU Follow-up Program are invited into the NICU to meet with families. In addition, MANA clinicians regularly attend the follow-up clinic to promote continuity of care and provide a welcoming face to returning families. The result has been a remarkable increase in our ability to assess long-term outcomes of the most vulnerable infants:
Examples of MANA’s current commitment to follow-up care include:
- Vision Screening Follow-up: MANA clinicians are engaged in a grant-funded program to assess best practices for the follow-up of infants at risk of visual disturbances.
- Osteopenia Follow-up: The most premature infants in the NICU, those born at less than 28 weeks gestation, are at risk for significant deficiency of bone mineralization. A great deal of mineral accretion in the fetus normally occurs in the third trimester of pregnancy, after these infants have been delivered. Those deemed to be at risk for osteopenia at the time of NICU discharge are followed closely in the NICU Follow-up Program so that they are identified early enough for corrective nutritional measures to be taken.
- Clinical Trials: Long-term follow-up is an essential element of many clinical trials. Whether we are evaluating the efficacy of novel infant formulas or therapeutic hypothermia for hypoxic-ischemic encephalophathy, the NICU Follow-up Program represents a key service to our patients and their families.